| Nov 4 |
Hologic GAAP EPS of $1.01 beats by $0.18, revenue of $987.9M beats by $11.21M
|
| Nov 4 |
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
|
| Oct 30 |
Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
|
| Oct 30 |
Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics
|
| Oct 28 |
Hologic: Continued Room Amidst Bolt-On M&A Efforts
|
| Oct 28 |
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know
|
| Oct 28 |
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 28 |
FDA advises clinicians to stop using Hologic radiographic markers
|
| Oct 25 |
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
|
| Oct 25 |
Will Non-COVID-19 Diagnostics Sales Drive Hologic's Q4 Earnings?
|
